MASLD (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE)
Clinical trials for MASLD (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE) explained in plain language.
Never miss a new study
Get alerted when new MASLD (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE) trials appear
Sign up with your email to follow new studies for MASLD (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diet or drugs? new study tests if fasting beats pills for fatty liver disease
Disease control ENROLLING_BY_INVITATIONThis study tests whether a Mediterranean diet combined with intermittent fasting can reduce liver scarring (fibrosis) better than the weight-loss medication naltrexone/bupropion. About 70 adults with overweight or obesity and heart or metabolic risks (like type 2 diabetes or high…
Matched conditions: MASLD (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE)
Phase: PHASE4 • Sponsor: Carmen Dietvorst • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New study aims to catch fatty liver early in kids with simple waist measurement
Disease control OngoingThis study focuses on children aged 7 to 11 with a high waist-to-height ratio, a sign of possible fatty liver disease (MASLD). Researchers will test a simple screening method and a lifestyle program involving school, clinic, family, and community support. The goal is to improve e…
Matched conditions: MASLD (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE)
Phase: NA • Sponsor: Ningbo No. 1 Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Major study aims to spare patients painful liver biopsies
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 1,689 adults with fatty liver disease (MASLD) or MASLD with increased alcohol intake (MetALD) to see if non-invasive tests like MRI and Fibroscan can accurately track disease progression. The goal is to reduce the need for liver biopsies in future research and …
Matched conditions: MASLD (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE)
Sponsor: HRI-MAIL-NIT • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Diabetes and liver danger: new study follows 317 patients to uncover hidden risks
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 317 adults with type 2 diabetes who were first examined between 2019 and 2023. Researchers will repeat advanced liver scans, blood tests, and body composition measurements to see how liver fat and scarring change over time. The goal is to find out who is most a…
Matched conditions: MASLD (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE)
Sponsor: Linkoeping University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC